Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP trial of switching acenocoumarol to phenprocoumon during point-of-care INR monitoring
NL-OMON22099Unknown
- Sponsor
- Erasmus MC
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of phenprocoumon and acenocoumarol in None, sponsored by Erasmus MC. Primary endpoint: Percentage of time in therapeutic range. Status: unknown.
02
Drugs
phenprocoumonacenocoumarol
Beyond the preview
Go deeper on NL-OMON22099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22099.